A single-residue change in the HIV-1 V3 loop associated with maraviroc resistance impairs CCR5 binding affinity while increasing replicative capacity

BACKGROUND: Maraviroc (MVC) is an allosteric CCR5 inhibitor used against HIV-1 infection. While MVC-resistant viruses have been identified in patients, it still remains incompletely known how they adjust their CD4 and CCR5 binding properties to resist MVC inhibition while preserving their replicativ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Retrovirology
Main Authors: Garcia-Perez, Javier, Staropoli, Isabelle, Azoulay, Stéphane, Heinrich, Jean-Thomas, Cascajero, Almudena, Colin, Philippe, Lortat-Jacob, Hugues, Arenzana-Seisdedos, Fernando, Alcami, Jose, Kellenberger, Esther, Lagane, Bernard
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4470041/
https://ncbi.nlm.nih.gov/pubmed/26081316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-015-0177-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados